POLY MEDICURE LTD. - 531768 - Clarification
With reference to Movement in Volume, Poly Medicure Ltd has submitted to BSE a copy of Clarification is enclosed.13-07-2020
POLY MEDICURE LTD. - 531768 - Clarification
With reference to Movement in Volume, Poly Medicure Ltd has submitted to BSE a copy of Clarification is enclosed.POLY MEDICURE LTD. - 531768 - Clarification sought from Poly Medicure Ltd
The Exchange has sought clarification from Poly Medicure Ltd on July 13, 2020, with reference to Movement in Volume.The reply is awaited.POLY MEDICURE LTD. - 531768 - Closure of Trading Window
Dear Sir/Madam, It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with clarification given by BSE Circular Ref No.: LIST/COMP/01/2019-20 dated 02.04.2019 and NSE letter ref no: NSE/CML/2019/11 dated 02.04.2019 read with Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Wednesday, the 1st July, 2020 till the end of 48 hours after the declaration of Financial Results for the quarter ended on 30th June, 2020. The date of the Board Meeting to consider the above financial results would be intimated to the Stock Exchange in due course. You are hereby requested to please take the above information on your records.POLY MEDICURE LTD. - 531768 - Disclosure Of Related Party Transactions For The Half Year Ended On 31St March, 2020 Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015
Dear Sir/Madam, Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, pleased find enclosed herewith disclosure of Related Party Transactions drawn in accordance with applicable Accounting Standards for the half-year ended on 31st March, 2020. Kindly take a note of the same for your further needful and oblige us.POLY MEDICURE LTD. - 531768 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Dear Sir, Please find attached Annual Secretarial Audit Report for the year ended 31st March 2020. Please take this in record. Thanking You, Avinash Chandra Company SecretaryPOLY MEDICURE LTD. - 531768 - Results -Financial(Standalone & Consolidated)Financial Year Ended 31St March, 2020
Dear Sir, Please find attached Results -Financial(Standalone & Consolidated)Financial Year ended 31st March, 2020. Thanking You, Avinash Chandra Company SecretaryPOLY MEDICURE LTD. - 531768 - Intimation Of Appointment Of Additional Director
Dear Sir, In continuation to our letter dated 5th June, 2020 as Outcome of Board Meeting and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Please find enclosed herewith a brief profile of Mr. Amit Khosla. We further confirm that Mr. Amit Khosla is not related to any of the Directors of the Company. The above is for your information and record.POLY MEDICURE LTD. - 531768 - Outcome Of The Board Meeting Of The Company
Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 05th June, 2020, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the enclosed businesses: